Press Releases

See what's up at Voluntis

Press Release 30 November 2020
Informations relatives au nombre total de droits de vote et d’actions
Learn more
Press Release 23 November 2020
Voluntis successfully completes a capital increase of €5.9 million and finalizes the financing of its strategic roadmap
Learn more
Press Release 18 November 2020
Launch of a new R&D program to extend the Theraxium platform supported by a loan from BPIFrance
Learn more
Press Release 16 November 2020
Voluntis receives CE Mark for Oleena, key milestone to the future commercialization of its digital therapeutic for oncology
Learn more
Press Release 12 November 2020
Voluntis extends its digital therapeutics cloud infrastructure worldwide with Microsoft
Learn more
Press Release 29 October 2020
Voluntis and Redox enter into new partership to enable interoperability of digital therapeutics with Electronic Health Records
Learn more
Press Release 28 October 2020
Project to transfer the listing of securities to the Euronext Growth market in Paris
Learn more
Press Release 6 October 2020
Voluntis announces issuance of US patent for the proprietary algorithm engine of its Theraxium digital therapeutic platform
Learn more